INS and cystic fibrosis: For example Thomassen et al. showed that overall, no significant improvement in glucose metabolism or insulin secretion was observed after the treatment of 5 Phe508del-homozygous CF patients (ages 13–33) with LUMA/IVA for over 6–8 weeks.